Board/Management Information • Dec 8, 2023
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 1051W
Revolution Beauty Group PLC
08 December 2023
8 December 2023
Revolution Beauty Group plc
("Revolution Beauty", the "Group" or the "Company")
Change of Adviser and AIM Rule 17 Schedule Two(g) Update
Revolution Beauty Group plc (AIM: REVB), the multi-channel mass beauty innovator, is pleased to announce the appointment of Liberum Capital Limited ("Liberum") as nominated adviser and joint corporate broker with immediate effect. Liberum were previously engaged as the Company's joint corporate broker. Zeus will remain as joint corporate broker.
For further information please contact:
Investor Relations
Lauren Brindley, CEO
Elizabeth Lake, CFO
Joint Corporate Brokers
Liberum (NOMAD): Edward Thomas / Dru Danford / John More
Tel: +44 (0) 203 100 2222
Zeus: Nick Cowles / Jamie Peel / Ben Robertson
Tel: +44 (0) 161 831 1512
Media enquiries
Headland Consultancy: Matt Denham / Will Smith / Antonia Pollock
Tel: +44 (0)20 3805 4822
Existing Board - AIM Rule 17 Disclosures
Revolution Beauty also announces the following information relating to directors' disclosure under Schedule Two, paragraph (g) of the AIM Rules for Companies as an update to the information provided in the announcement published on 31 August 2023 regarding the appointment of Colin Henry as Independent Non-Executive Director.
Colin was a director of CV Financial Services Limited until 24 May 2016 which went into creditors voluntary liquidation on 8 December 2014 and was dissolved on 24 May 2016. There were no third party creditors and none came to light during the process of liquidation.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPTRBBTMTJMTLJ
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.